Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.67 USD 0.00(0%)
Last update at 2026-10-27T13:30:00Z
Market Cap
48.46M
P/E
22.00

Momentum Score

…

Carclo plc, together with its subsidiaries, provides plastic components for the life sciences, aerospace, and advanced industries in the United Kingdom, France, the Czech Republic, China, India, rest of Europe, North America, and internationally. It operates through two segments, CTP and Speciality. The company offers in vitro diagnostics and medical devices, including microfluidic, pipettes, cuvettes, multiwells, and capillary blood sampling devices; drug delivery products comprising inhaler systems and auto injector pens; and injection moulded components for ATM cash storage and dispensing systems, lighting control, and electronics and megatronics. It also provides design and engineering solutions consisting of validation, automation, and education services; and manufacturing services, which include injection moulding, assembly and welding, decoration, and supply chain solutions. In addition, the company offers aerospace mechanical cable assemblies and machined components under the Bruntons and Jacottet brands; speciality optics; and fresnel lenses. Carclo plc was incorporated in 1924 and is headquartered in Mitcham, the United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.67
Low
0.67
High
52 Week Price Range
0.28
Low
0.84
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Carclo plc is a UK specialty engineering group that makes precision plastic and metal components and optical solutions for healthcare, industrial and lighting customers. Long-term growth may be supported by medical-device demand, broader use of precision optics and outsourcing to specialist manufacturers. It appears positioned by niche engineering capabilities and geographic breadth to access higher-growth end markets.
Key risks are customer concentration and cyclicality, margin pressure from raw-material and currency swings, and execution risk in maintaining manufacturing quality.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.67
Dividend Yield
-
Revenue TTM
117.50M
Revenue Per Share
1.60
Gross Profit TTM
69.82M
Debt / Equity
-2.54
ROE
-44.67%
Net Debt
19.20M
ROCE
16.63%
Diluted EPS TTM
0.03

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax 2.65M -3.80M -3.11M 7.77M 9.20M
Minority interest - 0.00M 0.00M 0.00M -0.03M
Net income 0.87M -3.30M -4.88M 5.80M 7.41M
Selling general administrative 1.73M 1.46M 0.41M 0.28M 0.33M
Selling and marketing expenses 38.06M 40.42M 25.29M 28.03M 26.58M
Gross profit 73.54M 72.10M 31.90M 36.60M 34.62M
Reconciled depreciation 6.54M 7.93M 8.03M 7.03M 5.98M
Ebit 8.15M 2.21M 5.09M 8.29M 7.71M
Ebitda 14.69M 10.15M 14.98M 17.52M 15.96M
Depreciation and amortization 6.54M 7.93M 9.90M 9.23M 8.25M
Operating income 7.58M 1.79M 5.09M 8.29M 7.71M
Other operating expenses 113.64M 130.88M 171.82M 160.57M 140.70M
Interest expense 5.50M 6.01M 4.07M 3.07M 2.56M
Tax provision 1.78M -0.50M 1.44M 0.81M 0.46M
Interest income 0.57M 0.42M 0.22M 0.08M 0.04M
Net interest income -4.93M -5.59M -3.75M -2.99M -2.66M
Income tax expense 1.78M -0.50M 1.77M 1.06M 0.63M
Total revenue 121.22M 132.67M 176.91M 168.86M 148.41M
Total operating expenses 65.96M 70.31M 26.81M 28.31M 26.91M
Cost of revenue 47.68M 60.57M 145.02M 132.25M 113.79M
Total other income expense net -4.93M -5.59M -8.19M -0.52M 1.50M
Discontinued operations - - - 0.69M 1.20M
Net income from continuing ops 0.87M -3.30M -3.96M 5.11M 6.21M
Net income applicable to common shares - - - 5.80M 7.41M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 97.03M 100.94M 122.67M 128.20M 116.02M
Intangible assets 0.13M 0.17M 0.45M 0.75M 0.78M
Other current assets 3.87M 3.40M - 0.27M -
Total liab 108.88M 97.28M 111.07M 103.78M 108.11M
Total stockholder equity -11.81M 3.69M 11.63M 24.44M 7.94M
Other current liab 11.91M 10.11M 8.13M 6.08M 7.21M
Common stock 3.67M 3.67M - 3.67M 3.67M
Capital stock 3.67M 3.67M 3.67M 3.67M 3.67M
Retained earnings -29.49M -14.56M -8.64M 5.93M -8.43M
Other liab - - - 33.96M 42.53M
Good will 21.67M 22.03M 23.01M 21.96M 21.07M
Other assets - 26.48M - 1.52M 0.50M
Cash 10.74M 5.97M 10.35M 12.35M 15.48M
Total current liabilities 48.01M 28.53M 31.99M 28.02M 27.58M
Current deferred revenue - 3.00M - - -
Net debt 19.20M 29.46M 22.49M 21.54M 20.54M
Short term debt 24.84M 11.23M - - -
Short long term debt 22.09M 6.85M 1.34M 1.40M 3.62M
Short long term debt total 29.95M 39.91M - - -
Other stockholder equity 7.36M 7.36M - 7.49M 5.33M
Property plant equipment - - - 46.96M 43.22M
Total current assets 37.99M 37.81M 52.70M 57.00M 50.46M
Net tangible assets - - - 1.73M -13.91M
Short term investments - 1.57M - - -
Net receivables 13.45M 17.15M 24.14M 24.95M 20.79M
Long term debt 0.10M 21.89M 31.50M 32.48M 32.41M
Inventory 9.93M 11.29M 15.20M 16.99M 12.82M
Accounts payable 9.70M 9.70M 13.09M 13.40M 8.61M
Accumulated other comprehensive income 6.65M 7.22M - - -
Non currrent assets other 0.76M -8.08M - - -
Non current assets total 59.05M 63.13M 69.97M 71.20M 65.56M
Capital lease obligations 7.77M 11.17M 11.87M 10.87M 7.05M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments -0.45M -2.40M -0.81M -4.15M -6.01M
Change to liabilities - - - 4.89M 4.71M
Total cashflows from investing activities -0.45M -2.40M - -4.15M -6.01M
Net borrowings -2.62M -8.38M - -2.49M 5.43M
Total cash from financing activities -7.00M -12.14M -5.77M -3.27M 6.97M
Net income 0.87M -3.30M -4.88M 6.71M 8.57M
Change in cash 4.01M -4.38M -3.45M -5.15M -2.58M
Begin period cash flow 5.97M 10.35M 16.22M 21.36M 23.94M
End period cash flow 9.98M 5.97M 12.77M 16.22M 21.36M
Total cash from operating activities 11.48M 10.37M 4.92M 4.00M 11.64M
Depreciation 6.54M 7.93M 9.90M 9.23M 8.25M
Other cashflows from investing activities 0.61M 0.54M - 0.77M 1.29M
Change to inventory 1.31M 3.43M 1.90M -5.01M 1.06M
Change to account receivables 2.18M 6.11M 0.90M -6.13M -2.48M
Other cashflows from financing activities -4.38M -3.76M -3.86M -2.35M 16.14M
Change to netincome - - - -6.26M -8.67M
Capital expenditures 1.10M 2.94M 2.98M 6.49M 10.10M
Change in working capital 5.76M 4.62M -1.50M -4.72M 5.07M
Stock based compensation 0.03M 0.05M -0.03M 0.07M 0.00M
Other non cash items -1.73M 1.07M 1.35M -6.42M 6.48M
Free cash flow 10.38M 7.43M 1.94M -2.49M 1.55M

Peer Comparison*

Sector: Consumer Cyclical Industry: Auto Parts

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CCEGF
Carclo plc
-
-%
0.67 22.00 6.65 0.41 2.18 0.50 3.55
ORLY
O’Reilly Automotive Inc
0.62
0.69%
90.44 27.74 23.75 3.71 206.18 4.30 19.07
AZO
AutoZone Inc
13.60
0.43%
3156.76 25.25 24.21 3.05 13.38 3.65 17.03
SMTOF
Sumitomo Electric Industries Ltd
-
-%
10.96 17.90 20.41 0.01 2.40 1.31 9.00
SMTOY
Sumitomo Electric Industries Ltd ADR
-0.04
0.66%
6.00 16.31 18.35 0.01 2.16 1.31 9.05

Profile*

Carclo plc

Carclo plc, together with its subsidiaries, provides plastic components for the life sciences, aerospace, and advanced industries in the United Kingdom, France, the Czech Republic, China, India, rest of Europe, North America, and internationally. It operates through two segments, CTP and Speciality. The company offers in vitro diagnostics and medical devices, including microfluidic, pipettes, cuvettes, multiwells, and capillary blood sampling devices; drug delivery products comprising inhaler systems and auto injector pens; and injection moulded components for ATM cash storage and dispensing systems, lighting control, and electronics and megatronics. It also provides design and engineering solutions consisting of validation, automation, and education services; and manufacturing services, which include injection moulding, assembly and welding, decoration, and supply chain solutions. In addition, the company offers aerospace mechanical cable assemblies and machined components under the Bruntons and Jacottet brands; speciality optics; and fresnel lenses. Carclo plc was incorporated in 1924 and is headquartered in Mitcham, the United Kingdom.

47 Wates Way, Mitcham, United Kingdom, CR4 4HR

44 20 8685 0500

958

Name Title Year Born
Mr. Frank Doorenbosch CEO & Exec. Director NA
Mr. Phil White Exec. Officer NA
Mr. David Michael Bedford CFO & Director 1969
Mr. Stephen Nixon Interim Group Chief Operating Officer NA
Mr. Christopher J. Malley LED Technologies Divisional Chief Exec. 1967
Ms. Angie Wakes Group Company Sec. NA
Mr. Franciscus Lodewijk Paulus Doorenbosch CEO & Executive Director 1964
Mr. Eric G. Hutchinson CFO, Company Secretary & Executive Director 1955
Mr. Gabe Acuna Chief Technical Officer NA
Mr. Alan Hook Managing Director of Bruntons NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…